Gregory R Friberg Insider Profile
4 Followers
Gregory R Friberg, EVP, Chief R&D Officer at BioMarin Pharmaceutical, holds 51.82K shares in BioMarin Pharmaceutical (Ticker: BMRN). Most recently, Gregory R Friberg Sold 3,281 shares of BioMarin Pharmaceutical on May 11, 2026 for an estimated value of $176.68K.
Gregory R Friberg BioMarin Pharmaceutical (BMRN)EVP, Chief R&D Officer
BioMarin Pharmaceutical (BMRN)
EVP, Chief R&D Officer
Ranked #48,823 out of 107,360 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+8.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Gregory R Friberg's holdings
Insider Roles
EVP, Chief R&D Officer
Roles that Gregory R Friberg holds in companies
Most Profitable Insider Trade
The most profitable trade made by Gregory R Friberg
Gregory R Friberg's Trading History
List of latest transactions for each holding click on a transaction to see Gregory R Friberg's performance on stock
You May Also Like
Gregory R Friberg insider profile FAQ
What is the percentage of profitable transactions made by Gregory R Friberg?
The percentage of profitable transactions made by Gregory R Friberg is 100%.
What is the average return per transaction made by Gregory R Friberg?
The average return per transaction made by Gregory R Friberg is 8.30%.
What stocks does Gregory R Friberg hold?
Gregory R Friberg holds: BMRN stocks.
What was Gregory R Friberg’s latest transaction?
Gregory R Friberg latest transaction was an Informative Sell of $176.68K.
What was Gregory R Friberg's most profitable transaction?
Gregory R Friberg’s most profitable transaction was an Informative Sell of BMRN stock on February 26, 2026. The return on the trade was 15.20%.
What is Gregory R Friberg's role in BioMarin Pharmaceutical?
Gregory R Friberg's role in BioMarin Pharmaceutical is EVP, Chief R&D Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.